Related Content
July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...
The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...
May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...
March 16, 2023 — Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the ...
March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...
September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...
September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...
July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...
July 5, 2022 — A BIO-RESORT subgroup analysis of outcomes in small coronary vessels (<2,5mm) evaluated the efficacy and ...